Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp ® (Amgen) in Treatment of Anemia in CKD Patients on Dialysis

Condition:   Chronic Kidney Disease Intervention:   Biological: Stimus Sponsors:   Nanogen Pharmaceutical Biotechnology Joint Stock Company;   Vietstar Biomedical Research;   Clinical Research Consultants, Inc.;   Clinical Research Viet Nam Skill Training And Consultant Company Limited Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials